Alcon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON, and when can generic versions of ALCON drugs launch?
ALCON has fifty-seven approved drugs.
There are thirty-nine US patents protecting ALCON drugs. There is one tentative approval on ALCON drugs.
There are two hundred and seventeen patent family members on ALCON drugs in thirty-one countries and seventy-eight supplementary protection certificates in fourteen countries.
Summary for Alcon
| International Patents: | 217 |
| US Patents: | 39 |
| Tradenames: | 48 |
| Ingredients: | 40 |
| NDAs: | 57 |
| Patent Litigation for Alcon: | See patent lawsuits for Alcon |
| PTAB Cases with Alcon as patent owner: | See PTAB cases with Alcon as patent owner |
Drugs and US Patents for Alcon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 10,882,840 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 10,654,844 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Alcon | MYDRIACYL | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 012111-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Alcon Labs Inc | SIMBRINZA | brimonidine tartrate; brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 204251-001 | Apr 19, 2013 | RX | Yes | Yes | 9,421,265 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alcon Pharms Ltd | BETAXON | levobetaxolol hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 021114-001 | Feb 23, 2000 | 5,540,918*PED | ⤷ Try a Trial |
| Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 5,641,805*PED | ⤷ Try a Trial |
| Alcon | BSS PLUS | calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate | SOLUTION;IRRIGATION | 018469-001 | Approved Prior to Jan 1, 1982 | 4,443,432 | ⤷ Try a Trial |
| Alcon Pharms Ltd | NAVSTEL | calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate | SOLUTION;IRRIGATION | 022193-001 | Jul 24, 2008 | 5,409,904 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALCON drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.00% | ➤ Subscribe | 2008-11-28 |
| ➤ Subscribe | Ophthalmic Solution | 0.03% | ➤ Subscribe | 2004-12-23 |
International Patents for Alcon Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 111700880 | ⤷ Try a Trial |
| European Patent Office | 2442790 | ⤷ Try a Trial |
| Japan | 2022009979 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2010127330 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2365988 | 122018000012 | Germany | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
| 3461484 | 301101 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
| 1920764 | C300540 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001-002 20011127 |
| 0521471 | SPC/GB03/033 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
